Navigation Links
FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery
Date:2/1/2012

r treatment period in the 36-month group and 13% in the 12-month group(1).

Novartis provided the study drug and supported the study financially. Additional funding was received from the Academy of Finland, Cancer Society of Finland, Sigrid Juselius Foundation and Helsinki University Research Funds.

About Gleevec
Gleevec® (imatinib mesylate) tablets are indicated for the treatment of patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) that are cancerous, cannot be surgically removed, and/or have spread to other parts of the body. Gleevec is also approved for use after surgery in patients that have had their KIT (CD117)-positive GIST completely removed.

Gleevec Important Safety Information
Gleevec can cause fetal harm when administered to a pregnant woman. Women taking Gleevec should not become pregnant, and should be advised of the potential risk to the unborn child.

Gleevec is often associated with edema (swelling) and serious fluid retention. Studies have shown that edema (swelling) tended to occur more often among patients who are 65 and older or those taking higher doses of Gleevec.

Cytopenias (reduction or lack of certain cell elements in blood circulation), such as anemia, have occurred. If the cytopenia is severe, your doctor may reduce your dose or temporarily stop your treatment with Gleevec.

Severe congestive heart failure and left ventricle dysfunction have been reported, particularly in patients with other health issues and risk factors. Patients with heart disease or risk factors or history of renal failure will be monitored and treated for the condition.

Severe liver problems (hepatotoxicity) may occur. Cases of fatal liver failure and severe liver injury requiring liver transplants have been reported with both short-term and long-term use of Gleevec.

Bleeding may occur. Severe gastrointestinal (GI) bleeding has been reported in
'/>"/>

SOURCE Novartis
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013  Avanir Pharmaceuticals, Inc. (NASDAQ: ... overview of the company at the following conferences. ... Presentation date: Wednesday May 29, 2013 , Presentation time: ... Healthcare Conference , Presentation date: Wednesday June 5, 2013 ... A live webcast and 30-day archive of ...
(Date:5/22/2013)... , May 22, 2013  Grifols, a global healthcare ... presented results from a study demonstrating that a higher ... [Human]) increased levels of the alpha 1 protein ... levels that are considered within the normal range for ... in which low levels of the alpha 1 ...
(Date:5/22/2013)... May 22, 2013 Varian Medical Systems ... received 510(k) clearance from the U.S. Food and ... processing workstation that combines radio frequency (RF) and ... Nexus DRF Digital X-Ray Imaging System™ has the ... receptors, including CCD cameras and commercially available flat-panel ...
Breaking Medicine Technology:Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System 2
... Science Corporation , a global leader in automated external ... devices, announced today that the Japan Ministry of ... its Powerheart® G3 AED. The company is partnering with ... Omron is a leading healthcare company dedicated to prevention ...
... (Nasdaq: CPHD ) today announced that it will ... 30, 2011, on Thursday, July 21, 2011, after the close ... management presentation at 2 p.m. Pacific Time on Thursday, July ... webcast, please visit Cepheid,s website at www.cepheid.com/investors at ...
Cached Medicine Technology:Cardiac Science Gains Japanese Regulatory Approval for Powerheart AED 2Cardiac Science Gains Japanese Regulatory Approval for Powerheart AED 3Cardiac Science Gains Japanese Regulatory Approval for Powerheart AED 4Cepheid Schedules 2011 Second Quarter Financial Results Announcement and Webcast 2
(Date:5/22/2013)... challenges previous research that suggests umpire discrimination exists ... collaboration between researchers at U-M and the universities ... controversial argument over whether MLB umpires discriminate by ... same race. It found little statistical evidence to ... of sport management at the U-M School of ...
(Date:5/22/2013)... May 22 (HealthDay News) -- Over the next two ... States is expected to more than double, topping more ... The main factor driving the increase: an aging ... and the American Stroke Association, was published May 22 ... absolutely strain the health care system," Dr. Bruce Ovbiagele, ...
(Date:5/22/2013)... that hospitals may be reaping enormous income for ... bloodstream infections contracted in their intensive care units. ... in the American Journal of Medical Quality ... who develops an avoidable central line-associated bloodstream infection ... for than a similar infection-free patient. Moreover, hospitals ...
(Date:5/22/2013)... Phelps Memorial Hospital Center in Sleepy ... Center for individuals who would like to be screened ... is the deadliest form of cancer for both men and ... from lung cancer than from breast, colon and prostate cancer ... survival rates. It is well established that routine mammography ...
(Date:5/22/2013)... RI (PRWEB) May 22, 2013 Hurricane ... weatherproofing your home. That’s why Amica Insurance ... coverages for the upcoming hurricane season. , “An important ... said Bryan Cook, a senior assistant vice president at ... needs is before the threat of a storm.” , ...
Breaking Medicine News(10 mins):Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2
... than 40 years, Earth observing satellites have delivered valuable ... understanding and improved management of the Earth and its ... decision-makers are faced with responding to environmental change, managing ... security issues. , In order to address these needs, ...
... 28 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, Inc. (Amex: ... Company,), a,manufacturer, marketer and distributor of pharmaceutical, medicinal ... has engaged MSPC,Certified Public Accountants and Advisors LLP ... 2008. The Company terminated its,contract with Sherb & ...
... Storage Systems, Software And Services To Deliver ... Higher Performance and Greater Reliability, ... EMC ),the world leader in information infrastructure solutions, announced ... headquarters,of Boston Health Care for the Homeless Program (BHCHP), ...
... panel of judges to select winning online ... Microsoft Corp. has,increased award funding from ... 200 proposals from leading academic and research ... http://www.newscom.com/cgi-bin/prnh/20000822/MSFTLOGO ), Proposals represent a ...
... Contest and More than ... $10,000 in Cash and Prizes, HOFFMAN ESTATES, Ill., May ... grand prize winner of the,annual "New Day Your Way" contest, which is ... their fitness goals,in 2008. During the 12-week contest, Kmart provided more than ...
... German . , A measuring procedure ... investigate in some detail the behaviour of magnetic nanoparticles ... (with a size of some few to several hundred ... The particles serve as a carrier for drugs: "loaded" ...
Cached Medicine News:Health News:European conference addresses increasing demand for EO data 2Health News:China Sky One Medical, Inc. Engages Moore Stephens as New Independent Auditor 2Health News:China Sky One Medical, Inc. Engages Moore Stephens as New Independent Auditor 3Health News:EMC Strengthens Information Infrastructure for Boston Health Care for the Homeless Program 2Health News:EMC Strengthens Information Infrastructure for Boston Health Care for the Homeless Program 3Health News:Microsoft HealthVault Be Well Fund Increased to $4.5 Million 2Health News:Microsoft HealthVault Be Well Fund Increased to $4.5 Million 3Health News:Microsoft HealthVault Be Well Fund Increased to $4.5 Million 4Health News:Microsoft HealthVault Be Well Fund Increased to $4.5 Million 5Health News:The Weight Is Over: Five Winners Lose 194 Pounds as Kmart Encourages 24,000 Americans to Achieve Healthier Lifestyle 2Health News:Magnetic nanoparticles: Suitable for cancer therapy? 2
... Wampole EBV ELISA test panel ... assays for the determination of ... for Viral Capsid Antigen (VCA), ... Antigen (EBNA). Most Wampole EBV ...
Herpes Simplex Virus Group IgG....
Cytomegalovirus IgG ELISA....
Blunt tipped forceps with tungsten carbide treated jaws for enhanced gripping and removal of large sized foreign bodies....
Medicine Products: